Related Experiment Video
Updated: Apr 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Aberrant expression of p-Smad3 in oral carcinogenesis
Sopee Poomsawat1, Jirapa Punyasingh, Paisarn Vejchapipat
1Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Yothi Street, Bangkok, 10400, Thailand, spoomsawat@yahoo.com.
Objective:
Smads are the keys of transforming growth factor β (TGFβ) signaling cascade and play a crucial role in many cancers. Once TGFβ receptors are activated, Smad2 and Smad3 are phosphorylated and form complexes with Smad4. These complexes translocate from the cytoplasm to the nucleus where they regulate the target genes. The subcellular localization of phosphorylated Smad3 (p-Smad3) in oral carcinogenesis has never been reported. This study investigated the subcellular distribution of p-Smad3 in oral squamous cell carcinoma (OSCC) and oral leukoplakia (OL) with and without dysplasia.
Materials And Methods:
Expression of p-Smad3 was immunohistochemically examined in 150 samples including OSCC, OL with and without dysplasia, and normal mucosa (NM). Cytoplasmic and nuclear positive cells were counted separately. The results were present as the frequency of positive cases.
Results:
Cytoplasmic and/or nuclear staining for p-Smad3 was detected. The frequency of cytoplasmic expression in OL with dysplasia was significantly higher than that in NM. The numbers of cytoplasmic expression and cytoplasmic plus nuclear expression in OSCC were significantly higher than those in NM and OL with and without dysplasia.
Conclusions:
The overexpression of cytoplasmic p-Smad3 in OL with dysplasia and in OSCC suggests that p-Smad3 is in the nonfunctional state. Thus, the growth inhibitory effect of p-Smad3 is diminished during oral carcinogenesis. The cytoplasmic plus nuclear staining of p-Smad3 was aberrant in OSCC.
Clinical Relevance:
The cytoplasmic staining of p-Smad3 may serve as a marker for oral premalignant lesions whereas the cytoplasmic plus nuclear staining of p-Smad3 may serve as a marker for OSCC.
Insights
Phosphorylated Smad3 (p-Smad3) accumulates in the cytoplasm of oral premalignant lesions and oral squamous cell carcinoma (OSCC). This cytoplasmic p-Smad3 suggests a diminished growth inhibitory effect, with aberrant nuclear localization indicating OSCC.
Area of Science:
- Oncology
- Cell Biology
- Molecular Signaling
Background:
- Smads are crucial mediators of transforming growth factor β (TGFβ) signaling.
- TGFβ/Smad pathway dysregulation is implicated in various cancers, including oral squamous cell carcinoma (OSCC).
- The role of phosphorylated Smad3 (p-Smad3) subcellular localization in oral carcinogenesis remains uncharacterized.
Purpose of the Study:
- To investigate the subcellular distribution of p-Smad3 in oral leukoplakia (OL) with and without dysplasia and in OSCC.
- To correlate p-Smad3 localization with oral carcinogenesis progression.
Main Methods:
- Immunohistochemical analysis of p-Smad3 expression in 150 oral tissue samples (OSCC, OL with/without dysplasia, normal mucosa).
- Quantification of cytoplasmic and nuclear p-Smad3-positive cells.
- Statistical comparison of p-Smad3 expression frequencies across different tissue types.
Main Results:
- Cytoplasmic p-Smad3 expression was significantly elevated in OL with dysplasia compared to normal mucosa.
- Both cytoplasmic and cytoplasmic plus nuclear p-Smad3 expression were significantly higher in OSCC than in normal mucosa and OL.
- Aberrant cytoplasmic and/or nuclear p-Smad3 staining was observed.
Conclusions:
- Increased cytoplasmic p-Smad3 in OL with dysplasia and OSCC suggests a nonfunctional state, diminishing its growth-inhibitory role.
- Cytoplasmic p-Smad3 may serve as a biomarker for oral premalignant lesions.
- Cytoplasmic plus nuclear p-Smad3 staining could be a potential biomarker for OSCC.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...